Stay updated on Pyrotinib Plus Vinorelbine in HER2+ Breast Cancer Clinical Trial

Sign up to get notified when there's something new on the Pyrotinib Plus Vinorelbine in HER2+ Breast Cancer Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Pyrotinib Plus Vinorelbine in HER2+ Breast Cancer Clinical Trial page

  1. Check
    yesterday
    No Change Detected
  2. Check
    8 days ago
    Change Detected
    Summary
    Revision v3.5.0 was added and revision v3.4.3 was removed from the Record History.
    Difference
    0.1%
    Check dated 2026-03-18T20:23:37.000Z thumbnail image
  3. Check
    15 days ago
    Change Detected
    Summary
    A new revision entry v3.4.3 was added and the previous revision v3.4.2 was removed in the record history. This appears to be a minor maintenance update to the page history rather than a change to trial details.
    Difference
    0.1%
    Check dated 2026-03-11T20:00:24.000Z thumbnail image
  4. Check
    22 days ago
    No Change Detected
  5. Check
    43 days ago
    Change Detected
    Summary
    Added site revision v3.4.2 and removed the funding-lapse notice and the previous revision v3.4.1.
    Difference
    0.9%
    Check dated 2026-02-11T02:34:09.000Z thumbnail image
  6. Check
    51 days ago
    Change Detected
    Summary
    Added a site-wide notice about government funding and updated the page revision to v3.4.1; the previous revision v3.4.0 was removed.
    Difference
    0.9%
    Check dated 2026-02-04T00:22:28.000Z thumbnail image
  7. Check
    58 days ago
    Change Detected
    Summary
    The history page adds UI-related notes like Show glossary and color-coded indicators for additions and deletions, and updates revision labels (e.g., Revision: v3.4.0). These are formatting changes that do not alter core study content. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    1%
    Check dated 2026-01-27T23:30:07.000Z thumbnail image
  8. Check
    93 days ago
    Change Detected
    Summary
    The history now displays Revision: v3.3.3 in the footer. The items 'HHS Vulnerability Disclosure' and 'Revision: v3.3.2' have been removed.
    Difference
    0.2%
    Check dated 2025-12-23T08:44:45.000Z thumbnail image

Stay in the know with updates to Pyrotinib Plus Vinorelbine in HER2+ Breast Cancer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Pyrotinib Plus Vinorelbine in HER2+ Breast Cancer Clinical Trial page.